Establishment and validation of a cholesterol metabolism-related prognostic signature for hepatocellular carcinoma

被引:0
|
作者
Tang, Linsong [1 ,2 ,3 ,4 ]
Wei, Rongli [1 ,2 ,3 ,4 ]
Chen, Ronggao [3 ,4 ]
Fan, Guanghan [1 ,2 ,3 ,4 ]
Zhou, Junbin [1 ,2 ,3 ,4 ]
Qi, Zhetuo [1 ,2 ,3 ,4 ]
Wang, Kai [1 ,2 ,3 ,4 ]
Wei, Qiang [1 ,2 ,3 ,4 ]
Wei, Xuyong [1 ,2 ,3 ,4 ]
Xu, Xiao [1 ,2 ,3 ,4 ]
机构
[1] Zhejiang Univ, Affiliated Hangzhou Peoples Hosp 1, Sch Med, Key Lab Integrated Oncol & Intelligent Med Zhejian, Hangzhou 310006, Peoples R China
[2] Westlake Lab Life Sci & Biomed, Hangzhou 310024, Peoples R China
[3] NHC, Key Lab Combined Multiorgan Transplantat, Hangzhou 310003, Peoples R China
[4] Zhejiang Univ, Inst Organ Transplantat, Hangzhou 310003, Peoples R China
基金
中国国家自然科学基金;
关键词
Hepatocellular carcinoma; Cholesterol metabolism; Prognostic signature; Therapeutic response;
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Hepatocellular carcinoma (HCC) represents the most important type of liver cancer, the 5-year survival rate for advanced HCC is 2%. The heterogeneity of HCC makes previous models fail to achieve satisfactory results. The role of Cholesterol-based metabolic reprogramming in cancer has attracted more and more attention. In this study, we screened cholesterol metabolism-related genes (CMRGs) based on a system-atical analysis from TCGA and GEO database. Then, we constructed a prognostic signature based on the screened 5 CMRGs: FDPS, FABP5, ANXA2, ACADL and HMGCS2. The clinical value of the five CMRGs was validated by TCGA database and HPA database. HCC patients were assigned to the high-risk and low-risk groups on the basis of median risk score calculated by the five CMRGs. We evaluated the signature in TCGA database and validated in ICGC database. The results revealed that the prognostic signature had good prognostic performance, even among different clinicopathological subgroups. The function analysis linked CMRGs with KEGG pathway, such as cell adhesion molecules, drug metabolism-cytochrome P450 and other related pathways. In addition, patients in the high-risk group exhibited characteristics of high TP53 mutation, high immune checkpoints expression and high immune cell infiltration. Furthermore, based on the prognostic signature, we identified 25 most significant small molecule drugs as potential drugs for HCC patients. Finally, a nomogram combined risk score and TNM stage was constructed. These results indicated our prognostic signature has an excellent prediction performance. This study is expected to provide a potential diagnostic and therapeutic strategies for HCC. (c) 2022 The Author(s). Published by Elsevier B.V. on behalf of Research Network of Computational and Structural Biotechnology. This is an open access article under the CC BY-NC-ND license (http://creative-commons.org/licenses/by-nc-nd/4.0/).
引用
收藏
页码:4402 / 4414
页数:13
相关论文
共 50 条
  • [1] Establishment and validation of a cholesterol metabolism-related prognostic signature for hepatocellular carcinoma
    Tang, Linsong
    Wei, Rongli
    Chen, Ronggao
    Fan, Guanghan
    Zhou, Junbin
    Qi, Zhetuo
    Wang, Kai
    Wei, Qiang
    Wei, Xuyong
    Xu, Xiao
    [J]. COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL, 2022, 20 : 4402 - 4414
  • [2] Establishment and validation of a cholesterol metabolism-related prognostic signature for hepatocellular carcinoma
    Tang, Linsong
    Wei, Rongli
    Chen, Ronggao
    Fan, Guanghan
    Zhou, Junbin
    Qi, Zhetuo
    Wang, Kai
    Wei, Qiang
    Wei, Xuyong
    Xu, Xiao
    [J]. COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL, 2022, 20 : 4402 - 4414
  • [3] Development and Validation of a Propionate Metabolism-Related Gene Signature for Prognostic Prediction of Hepatocellular Carcinoma
    Xiao, Jincheng
    Wang, Jing
    Zhou, Chaoqun
    Luo, Junpeng
    [J]. JOURNAL OF HEPATOCELLULAR CARCINOMA, 2023, 10 : 1673 - 1687
  • [4] Development and validation of robust metabolism-related gene signature in the prognostic prediction of hepatocellular carcinoma
    Pan, Yangxun
    Zhang, Deyao
    Chen, Yuheng
    Li, Huake
    Wang, Jiongliang
    Yuan, Ze
    Sun, Liyang
    Zhou, Zhongguo
    Chen, Minshan
    Zhang, Yaojun
    Hu, Dandan
    [J]. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2023, 27 (07) : 1006 - 1020
  • [5] A Novel Metabolism-Related Signature as a Candidate Prognostic Biomarker for Hepatocellular Carcinoma
    Wang, Zhihao
    Embaye, Kidane Siele
    Yang, Qing
    Qin, Lingzhi
    Zhang, Chao
    Liu, Liwei
    Zhan, Xiaoqian
    Zhang, Fengdi
    Wang, Xi
    Qin, Shenghui
    [J]. JOURNAL OF HEPATOCELLULAR CARCINOMA, 2021, 8 : 119 - 132
  • [6] Identification of a prognostic signature of nine metabolism-related genes for hepatocellular carcinoma
    Tang, Chaozhi
    Ma, Jiakang
    Liu, Xiuli
    Liu, Zhengchun
    [J]. PEERJ, 2020, 8
  • [7] Prognostic Implication of a Novel Metabolism-Related Gene Signature in Hepatocellular Carcinoma
    Yuan, Chaoyan
    Yuan, Mengqin
    Chen, Mingqian
    Ouyang, Jinhua
    Tan, Wei
    Dai, Fangfang
    Yang, Dongyong
    Liu, Shiyi
    Zheng, Yajing
    Zhou, Chenliang
    Cheng, Yanxiang
    [J]. FRONTIERS IN ONCOLOGY, 2021, 11
  • [8] Identification and validation of palmitoylation metabolism-related signature for liver hepatocellular carcinoma
    Feng, Rui
    Cheng, Dexin
    Chen, Xiaochen
    Yang, Liu
    Wu, Hao
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2024, 692
  • [9] Establishment and validation of a prognostic signature for lung adenocarcinoma based on metabolism-related genes
    Wang, Zhihao
    Embaye, Kidane Siele
    Yang, Qing
    Qin, Lingzhi
    Zhang, Chao
    Liu, Liwei
    Zhan, Xiaoqian
    Zhang, Fengdi
    Wang, Xi
    Qin, Shenghui
    [J]. CANCER CELL INTERNATIONAL, 2021, 21 (01)
  • [10] Establishment and validation of a ferroptosis-related prognostic signature for hepatocellular carcinoma
    He, Yixian
    Wu, Yunyang
    Song, Mengqi
    Yang, Yanlong
    Yu, Yizhi
    Xu, Sheng
    [J]. FRONTIERS IN ONCOLOGY, 2023, 13